SPRI | Esophageal Squamous Cell Carcinoma: Diagnosis And Treatment, 2nd Edition (2020 EN)

Discussion in 'Medicine' started by Kanka, Jun 25, 2020.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,395
    Likes Received:
    485
    Trophy Points:
    83
    [​IMG]

    Author: Nobutoshi Ando (Editor)
    Full Title: Esophageal Squamous Cell Carcinoma: Diagnosis And Treatment, 2nd Edition
    Publisher: Springer; 2nd ed. 2020 edition (June 18, 2020)
    Year: 2020
    ISBN-13: 9789811541902 (978-981-15-4190-2), 9789811541896 (978-981-15-4189-6)
    ISBN-10: 9811541906, 9811541892
    Pages: 402
    Language: English
    Genre: Medicine: Oncology
    File type: EPUB (True), PDF (True)
    Quality: 10/10
    Price: 160.49 €


    This is the second edition of the book, covering a wide spectrum of the latest information relevant to diagnosis and treatment of esophageal squamous cell carcinoma (ESCC).

    In recent years the incidence rate of esophageal cancer has been increasing; however, the background characteristics of the cancer treatment are significantly different between Asian and Western countries. In tumor histology, ESCC associated with smoking and alcohol consumption is overwhelmingly prevalent in Asia, whereas adenocarcinoma associated with Barrett’s metaplasia is remarkably prevalent in the West. In Asia, especially in Japan, surgeons play a significant role in the management of esophageal cancer patients, while medical and radiation oncologists as well as surgeons are important in the West. Considering these East–West differences in management of esophageal cancer, evidence originating in Asia should be more widely disseminated globally.

    The contributing authors, who have great expertise in their areas of specialization, discuss details in terms of treatment of ESCC, including basic science, diagnosis, surgery, other treatment modalities, Japanese guidelines, and also valuable experiences from other Asian countries. Accordingly, this excellent collection of texts benefits not only oncologists, but all medical and biological researchers involved in the latest ESCC research.

    -------------